Feature | March 06, 2014

First Human Implants With Mitral Transcatheter Valve System

Edwards Lifesciences Fortis Mitral Transcatheter Valve System Heart Valve Repair

March 6, 2014 — Edwards Lifesciences Corp. announced the successful completion of the first three human implants of its Fortis mitral transcatheter heart valve. The Heart Team at St. Thomas’ Hospital in London performed them in February and March.


"These first patients had severe mitral valve disease and many risk factors that prevented them from undergoing surgery. After careful evaluation and close consultation with the patients and their families, we determined that this therapy could potentially extend and improve their lives. At this early stage, we are very pleased with the initial recoveries of these patients," said Vinayak Bapat, FRCS CTh, consultant cardiothoracic surgeon, St. Thomas' Hospital in London. 


The hospital's Heart Team ia also led by Martyn Thomas, M.D., FRCP, clinical director of cardiovascular services, and Jane Hancock, M.D., Ph.D., MRCP, consultant cardiologist specializing in imaging. They are experienced in less invasive valve procedures, including transcatheter aortic valve replacement (TAVR).


The Fortis transcatheter mitral valve features Edwards' most advanced, treated bovine pericardial tissue. It features a cloth-covered self-expanding frame designed to minimize paravalvular leak, and an anatomical anchoring system. This series of implants is being performed via a transapical approach to allow direct surgical access to the mitral valve complex.


Edwards expects these cases to be reviewed in the normal course at future medical meetings. The company's transcatheter mitral valve, which utilizes a transapical approach, is not for sale in any country.


For more information: www.edwards.com


Related Content

Products | Guidewires| July 28, 2015
The Safari2 Pre-Shaped Guidewire.
Feature | Heart Valve Repair| July 28, 2015
Boston Scientific announced CE Mark and U.S. Food and Drug Administration (FDA) clearance for the Safari2 Pre-Shaped...
Direct Flow Medical, Transcatheter Aortic Valve System, SALUS Trial, FDA
News | Heart Valve Repair| July 22, 2015
Direct Flow Medical Inc. received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug...
GlobalData, TAVR, Edwards, Medtronic, CoreValve Evolut R, Sapien 3

Sapien 3 image courtesy of Edwards Lifesciences

News | Heart Valve Repair| July 21, 2015
The recent U.S. Food and Drug Administration (FDA) approvals of two next-generation transcatheter aortic valve...
Biotronik, TAVI device, BIOVALVE trial, Hamburg, Germany
News | Heart Valve Repair| July 14, 2015
Biotronik announced the completion of the BIOVALVE first-in-human trial for its new transcatheter aortic valve. Study...
CardiAQ, Edwards, acquire, acquisition, Fortis, TMVI, mitral valve replacement

CardiAQ Transcatheter Mitral Valve Implantation System image courtesy of CardiAQ Valve Technologies

Feature | Heart Valve Repair| July 13, 2015
Edwards Lifesciences Corp. announced that it has agreed to acquire CardiAQ Valve Technologies Inc., a privately held...
CardiAQ Valve Technologies, TMVI, second generation, implantation, Tor Vergata
Feature | Heart Valve Repair| July 01, 2015
CardiAQ Valve Technologies (CardiAQ) announced that its second-generation transcatheter bioprosthetic mitral heart...
REDUCE FMR, Cardiac Dimensions, Carillon Mitral Contour System, FMR
Feature | Heart Valve Repair| June 30, 2015
Cardiac Dimensions announced the first patients have been enrolled in the REDUCE FMR clinical trial. REDUCE FMR is a...
Videos | Structural Heart| June 26, 2015
Interview with Steve Goldstein, M.D., director, noninvasive lab, Medstar Washington Heart Institute, Washington, D.C.
Medtronic, CoreValve Evolut R, FDA approval, TAVR, recapturable
Technology | June 23, 2015
Medtronic plc announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the recapturable, self-...
Overlay Init